CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY

Details for Australian Patent Application No. 2003243440 (hide)

Owner AVALON PHARMACEUTICALS, INC

Inventors EBNER, Reinhard

Pub. Number AU-A-2003243440

PCT Number PCT/US03/18060

PCT Pub. Number WO2003/104419

Priority 60/387,679 11.06.02 US

Filing date 10 June 2003

Wipo publication date 22 December 2003

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/387,679 11.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003243440

10 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243441-Audio coding system using characteristics of a decoded signal to adapt synthesized spectral components

2003243439-MEDICAL DEVICE FOR INTRALUMENAL DELIVERY OF PHARMACEUTICAL AGENTS